Envisagenics

Curated by Signal

AI-driven biotechnology company that focuses on the discovery and development of novel RNA splicing therapeutics

Life Sciences Technologyenvisagenics.com

Overview

AI-driven biotechnology company that focuses on the discovery and development of novel RNA splicing therapeutics. It offers SpliceCore, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data, using Artificial Intelligence.

Key facts

Founded: 2014
Headquarters: Long Island City, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Medical Edge Solutions
Developer of a medical device for central nervous therapy
Life Sciences TechnologyAtlanta, United States
Neopenda
Provider of wearable neonatal signs monitor
Life Sciences TechnologyChicago, United States
Thermaiscan
AI-based breast cancer diagnosis and detection software for providers
Life Sciences TechnologyUnited States

About Envisagenics

What does Envisagenics do?

AI-driven biotechnology company that focuses on the discovery and development of novel RNA splicing therapeutics.

Where is Envisagenics headquartered?

Envisagenics is headquartered in Long Island City, United States.

When was Envisagenics founded?

Envisagenics was founded in 2014.

Which sector is Envisagenics in?

Envisagenics operates in Life Sciences Technology.

Who are Envisagenics's competitors?

Companies similar to Envisagenics include Medical Edge Solutions, Neopenda, and Thermaiscan.